Edwards Lifesciences (EW) CVP Annette Bruls granted options and performance stock
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Edwards Lifesciences Corp executive Annette Bruls, CVP EMEACLA, received new equity awards and had a small tax-related share disposition. On May 7, 2026, she was granted 6,650 performance-based restricted stock units and 33,700 employee stock options tied to common stock.
The options have a conversion/exercise price of $82.76 per share and both the options and time-based restricted stock units vest in four equal annual installments starting one year after the grant date. The performance-based units, with a target of 6,650 shares, are scheduled to vest on May 7, 2029 based on performance over a three-year period, with payouts ranging from 0% to 200% of the target.
On May 8, 2026, 84 shares of common stock were disposed of at $82.76 per share to satisfy tax obligations, not as an open-market sale. Following these transactions, Bruls directly holds 20,737 shares of Edwards Lifesciences common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
Bruls Annette
Role
CVP, EMEACLA
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 84 | $82.76 | $7K |
| Grant/Award | Employee Stock Option (Right to Acquire) | 33,700 | $0.00 | -- |
| Grant/Award | Performance Rights | 6,650 | $0.00 | -- |
| Grant/Award | Common Stock | 6,650 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 20,737 shares (Direct, null);
Employee Stock Option (Right to Acquire) — 33,700 shares (Direct, null);
Performance Rights — 6,650 shares (Direct, null)
Footnotes (1)
- These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards.
Key Figures
Tax-withholding shares: 84 shares at $82.76
Time-based RSU grant: 6,650 shares
Stock option grant: 33,700 options at $82.76
+3 more
6 metrics
Tax-withholding shares
84 shares at $82.76
Common stock disposed on May 8, 2026 to cover tax
Time-based RSU grant
6,650 shares
Restricted stock units granted May 7, 2026, vest over four years
Stock option grant
33,700 options at $82.76
Employee stock options granted May 7, 2026 under long-term plan
Performance-based units target
6,650 units
Performance rights scheduled to vest May 7, 2029, 0%-200% payout range
Common shares held
20,737 shares
Direct holdings after reported transactions
Option expiration
May 6, 2033
End date for exercising 33,700 employee stock options
Key Terms
restricted stock units, Employee Stock Option (Right to Acquire), Long-Term Stock Incentive Compensation Program, performance rights, +1 more
5 terms
restricted stock units financial
"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Option (Right to Acquire) financial
"Employee Stock Option (Right to Acquire) transaction on May 7, 2026"
Long-Term Stock Incentive Compensation Program financial
"granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program"
performance rights financial
"Performance Rights transaction with underlying security title Common Stock"
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
tax-withholding disposition financial
"transaction_action: tax-withholding disposition for 84 shares at $82.76"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
FAQ
What equity awards did Edwards Lifesciences (EW) grant to Annette Bruls?
Annette Bruls received 6,650 performance-based restricted stock units and 33,700 employee stock options on May 7, 2026. Both awards relate to Edwards Lifesciences common stock under its Long-Term Stock Incentive Compensation Program and vest over multiple years.
What are the vesting terms of Annette Bruls’ new Edwards Lifesciences (EW) stock options?
The 33,700 employee stock options granted to Annette Bruls vest in four equal annual installments starting one year after May 7, 2026. They carry an exercise price of $82.76 per share and are scheduled to be exercisable through May 6, 2033.
How do the performance-based awards for Edwards Lifesciences (EW) executive Annette Bruls work?
Bruls’ performance-based restricted stock units have a target of 6,650 shares scheduled to vest on May 7, 2029. The final number of shares earned depends on achieving performance goals over a three-year period, ranging from 0% to 200% of the target award.
What compensation plan governs the new Edwards Lifesciences (EW) awards to Annette Bruls?
The restricted stock units, performance rights, and options granted to Annette Bruls on May 7, 2026 were issued under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program, which provides multi-year equity incentives to eligible executives.